ANN ARBOR, Mich.--Eli Lilly has launched an 18-month software development program with Nonlinear Dynamics here that is designed to accelerate Lilly's drug discovery process. A team of six Nonlinear research scientists will work with chemoinformatics specialists at Lilly to develop datamining software to help reduce the time and expense required to identify high-potential compounds for further drug development and preclinical evaluation. Pilot testing of Nonlinear's preproduction software is scheduled to begin later this year, according to Lilly.